To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes.

# Summary of HR 7212: Cannabinoid Hemp Products Regulation Bill **What the Bill Would Do** HR 7212 proposes to create federal regulations for hemp-derived cannabinoid products (such as CBD, delta-8, and delta-10 products). Currently, these products operate in a legal gray area under federal law. The bill would amend the Food, Drug, and Cosmetic Act to establish clear rules about how these products can be manufactured, labeled, tested, and sold to consumers. **Who It Affects** This bill would impact hemp farmers and manufacturers producing cannabinoid products, retailers selling these items, and consumers purchasing them.

It could also affect the FDA's regulatory responsibilities. States that have already created their own cannabinoid regulations might need to align with federal standards, depending on how the bill is written. **Current Status** The bill is currently in committee (not yet voted on by the full House), meaning it's still in the early stages of the legislative process. As of now, there is no public information about specific provisions, floor votes, or progress toward passage.